Thrivent Financial for Lutherans’s Virtus Biotech ETF BBP Stock Holding History

Thrivent Financial for Lutherans’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.32M	Buy	+44,897	New	+$3.91M	0.01%	1067

Other funds holding BBP

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Thrivent Financial for Lutherans's BBP Position: Q2 2026 in Review

Thrivent Financial for Lutherans opened a new position in Virtus Biotech ETF (BBP) in Q2 2026: 44,897 shares worth $4.32M. The stake represents 0.01% of the portfolio and ranks #1067 among its holdings.

26 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

Thrivent Financial for Lutherans held 44,897 shares of Virtus Biotech ETF worth $4.32M as of Q2 2026.
Virtus Biotech ETF was a new Thrivent Financial for Lutherans position in Q2 2026.
Virtus Biotech ETF made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1067 holding.
26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.